Connect with us

Technology

SimBioSys Achieves Second FDA Clearance for TumorSight™ Viz and Introduces TumorSight™ Clinical Decision Support for Breast Cancer Surgery

Published

2 days ago

on

CHICAGO, Nov. 4, 2024 /PRNewswire/ — SimBioSys®, a pioneering TechBio company at the forefront of digital precision medicine for cancer care, is proud to announce its second FDA 510(k) clearance for TumorSight™ Viz to expand its use by breast surgeons across the US. The updated TumorSight Viz now processes images with AI in a matter of minutes, integrates enhanced AI-driven tumor segmentation, enables seamless access to MRI images through direct connectivity to PACS systems, and has a first of its kind clinical decision support (CDS) feature that informs providers of evidence-based treatment options.  The addition of the CDS application is designed to enhance treatment planning and optimize oncologists’ decisions for early-stage breast cancer patients’ surgery.

With the recent FDA mandate which now requires breast density reporting for all women undergoing a mammogram, the demand for MRI as a supplementary screening tool is anticipated to rise. TumorSight Viz offers healthcare providers a powerful platform to visualize MRI data in 3D, supporting breast surgeons in tailoring treatment decisions to each patient’s unique tumor characteristics. The platform’s new CDS tool is designed to empower providers with advanced imaging insights and best practices for breast-conserving surgeries, aligning with updated NCCN guidelines promoting minimally invasive approaches when feasible and desired by patients.

“TumorSight Viz’s clinical decision support functionality provides a groundbreaking resource to assist breast surgeons and oncologists in considering the best possible approaches for each patient, fostering shared decision-making and precision care,” said Dr. Freya Schnabel from NYU.

TumorSight Viz: Key Enhancements

Enhanced AI-Driven Segmentation: Utilizing AI, TumorSight Viz is designed to deliver accurate and efficient tumor and tissue segmentation, enabling detailed 3D spatial visualization to support treatment planning.Clinical Decision Support (CDS) Application: The new CDS application is designed to provide data-driven insights for informing breast surgeons’ planning and preparation for surgeryDirect MRI Access via PACS Systems: TumorSight Viz now supports integration with middleware software as well as direct to PACS systems, allowing automated access to MRI images for analysis within the TumorSight platform and seamless fit into the clinician workflow.

Recent NCCN guideline updates emphasize the importance of individualized, data-supported treatment planning to support breast reconstruction and oncoplastic surgery as safe and effective options for eligible patients. TumorSight Viz aligns with these recommendations by enabling volume and anatomical measurements that assist surgeons in utilizing volume displacement techniques with a goal to achieve optimal cosmetic and functional outcomes. With the new CDS capability, surgeons are now better equipped with output measurements from TumorSight Viz that are aligned with standard of care guidelines to help plan lumpectomies more precisely, supporting both effective tumor removal and preservation of breast appearance.

A Game-Changer in Breast Cancer Care

Breast cancer affects more than 300,000 patients in the U.S. annually, many of whom now stand to benefit from SimBioSys’s enhanced TumorSight platform. By combining advanced AI-driven visualizations with CDS tools, TumorSight Viz is designed to provide surgeons, together with their patients, greater confidence in their treatment decisions.

“This second FDA clearance represents a significant milestone in our mission to redefine precision medicine for cancer,” said Barry Rosen, MD, Chief Medical Officer at SimBioSys. “TumorSight Viz’s latest capabilities elevate the standard of breast cancer care by allowing surgeons to make more informed choices, moving closer to an era of precision surgery that reduces variation and supports breast conservation when desired by the patient.”

TumorSight Viz is intended to be used in the visualization and analysis of breast magnetic resonance imaging (MRI) studies for patients with biopsy proven early-stage or locally advanced breast cancer.

About TumorSight™ Viz:
TumorSight™ Viz provides clinicians with 3D spatial visualizations of breast cancer using standard-of-care medical imaging (DCE MRI). Clear 3D “digital twin” renderings automatically display the tumor in the context of auto-segmented anatomical structures and provide key metrics used to inform the treatment planning process in conjunction with patient history and standard of care testing. TumorSight™ Viz received its original 510(k) FDA clearance in December 2023. Learn more about TumorSight Viz at https://simbiosys.com/tumorsight-viz.

About SimBioSys:
SimBioSys is a pioneering TechBio company leveraging artificial intelligence and computational modeling to harness the power of spatial biophysics to redefine precision medicine, transform patient care, and defeat cancer. By seeing cancer more completely, SimBioSys aims to empower clinicians and researchers with a more informed understanding of a patient’s tumor to optimally assess all available options and deliver on the promise of truly individualized patient care. To learn more, visit us at https://www.simbiosys.com/.

For media inquiries:
SimBioSys Marketing
media@simbiosys.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/simbiosys-achieves-second-fda-clearance-for-tumorsight-viz-and-introduces-tumorsight-clinical-decision-support-for-breast-cancer-surgery-302295938.html

SOURCE SimBioSys

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Edsol Communications Celebrates 14 Years of Service Excellence

Published

7 mins ago

on

November 6, 2024

By

Company has thrived by placing “People First, Then Technology” at the heart of its operations

FREDERICK, Md., Nov. 6, 2024 /PRNewswire-PRWeb/ — Edsol Communications, a premier IT solutions provider, is proud to mark 14 years of delivering top-tier technical support and services to small businesses, non-profits, educational institutions and government agencies. The company has thrived by placing “People First, Then Technology” at the heart of its operations. Since its conception, Edsol Communications’ impeccable work ethics and customer-focused culture have earned them a loyal client base. Their clients know they can rely on Edsol to provide dependable support whenever needed. The company’s dedication to customer service is evident in its availability and quick response to client needs, and its flexibility and commitment go above and beyond industry norms, making it a trusted partner to their clients.

“We’re very thankful for our clients, partners, and team members for their support and trust”, said Oscar Herrera, President & CEO of Edsol. “We know how important technology is for small businesses and organizations, and how our clients trust us and rely on us for running their organizations…”

Founded in 2010 by Oscar Herrera, Edsol has grown to serve its clients in the DMV area each year, including embassies, non-profits, educational institutions, government agencies, and commercial clients from a wide range of industries. Operating from its office in downtown Frederick, Edsol specializes in IT Managed Services, Help Desk Support, Network Administration, Cabling Infrastructure, Network Assessments, VoIP and Cloud Solutions, and Cybersecurity, offering services to ensure optimal performance for their clients’ systems. Unlike companies that branch out into unrelated fields, Edsol stays true to its core mission—delivering the best in IT support. By specializing exclusively in IT services, they remain at the forefront of industry trends, ensuring their clients receive top-quality support. As a small business, Edsol avoids the overhead costs that burden larger IT companies, passing those savings onto their clients while still delivering superior service.

“We are very thankful for our clients, partners, and team members for all their support and trust”, said Oscar Herrera, President and CEO of Edsol. “We know how important technology is for small businesses and organizations, and how our clients trust us and rely on us for running their organizations. We don’t take that lightly”.

As an SBA-certified 8(a), HUBZone small business and Minority Business Enterprise (MBE), Edsol Communications is dedicated to excellence and inclusion, contributing to economic growth in underutilized business zones. Their GSA 8(a) STARS III and Multiple Award Schedule (MAS) contract vehicles demonstrate their capability to deliver IT solutions that meet the rigorous demands of government and commercial clients alike.

For more information on Edsol Communications’ services, visit edsolcom.com or contact them directly at 301-802-9295.

Media Contact

Patricia Mir, Edsol Communications, LLC, 240-560-5990, patricia.mir@edsolcom.com, edsolcom.com

View original content to download multimedia:https://www.prweb.com/releases/edsol-communications-celebrates-14-years-of-service-excellence-302297718.html

SOURCE Edsol Communications, LLC

Continue Reading

Technology

OHRC and LCO release new tool to help organizations assess AI technologies to ensure they uphold human rights

Published

7 mins ago

on

November 6, 2024

By

TORONTO, Nov. 6, 2024 /CNW/ – Today, the Ontario Human Rights Commission (OHRC) and the Law Commission of Ontario (LCO) launched the Human Rights Impact Assessment for AI Technologies (“HRIA” or “the tool”), a tool to help assess and mitigate human rights impacts of AI systems in a broad range of applications.

“AI offers many benefits, but also has well-documented risks. The AI impact assessment released today is a practical, step-by-step tool that will help organizations identify and manage AI risks to human rights.  The LCO and OHRC have worked together to develop the first human rights impact assessment based on Canadian human rights law,” said Raj Anand, Chair of the Law Commission of Ontario Board of Governors.      

“While we are eager to harness the opportunities and benefits presented by the potential of AI, its use by public sector entities around the world has resulted in serious harms to individuals and communities. Thus, it is imperative that human rights protections be built into the foundation of any governing framework or regulation,” said Patricia DeGuire, Chief Commissioner, Ontario Human Rights Commission. “We are proud to have worked with the Law Commission of Ontario to create this tool that will help guide organizations in ensuring that their use of AI aligns with their human rights obligations.”

The HRIA is a step-by-step guide with examples and explanations, created for AI designers, developers, operators, and owners to identify, assess, minimize, or prevent discrimination and uphold human rights obligations throughout the lifecycle of an AI system.

The HRIA aims to:

Strengthen knowledge and understanding of human rights impacts;Provide practical guidance on human rights impacts, particularly in relation to non-discrimination and equality of treatment; andIdentify practical mitigation strategies and remedies to address bias and discrimination from AI systems.

The OHRC and the LCO call on the Ontario government, employers, and all other duty-holders to use the HRIA to ensure that the opportunities, benefits, and protections associated with the use of AI are available to all Ontarians without discrimination.

Quick Facts

The HRIA is based on internationally established guardrails on AI, which recognize the importance of human rights due diligence in use of these technologies.The Canadian Human Rights Commission (CHRC) also contributed to the development of the HRIA.The HRIA has two parts: Part A is an assessment of the AI system for human rights implications. In this section, organizations are asked questions about the purpose of the AI, the significance of the AI system, and the treatment of individual Canadians and communities. Part B is about mitigation. Once the AI system has been categorized, Part B provides a series of questions to assist organizations to minimize identified human rights issues in the given AI system. The HRIA does not constitute legal advice and does not provide a definitive legal answer regarding any adverse human rights impacts, including violations of federal or provincial human rights law or other relevant legislation.

SOURCE Ontario Human Rights Commission

Continue Reading

Technology

[Dynamax Pokémon] Best Pokémon GO Spoofer 2024 for iOS without Computer

Published

7 mins ago

on

November 6, 2024

By

NEW YORK, Nov. 6, 2024 /PRNewswire/ — Tenorshare has released version 2.10.2 of its iAnyGo iOS App, offering one-click access to Dynamax and Gigantamax Pokémon, enhancing the Pokémon GO experience. Optimized for iOS 18, the update enables users to quickly find shiny Gigantamax Pokémon, and join Max Battles. With Pokémon GO Spoofer iAnyGo, users can easily navigate the game world, copy GPS coordinates, and team up with friends to challenge Dynamax Pokémon, offering an enriched experience for all trainers.

“With iAnyGo iOS App version 2.10.2, users can now easily locate Dynamax and Gigantamax Pokémon with a single click and quickly share their locations using longitude and latitude coordinates. Trainers can quickly join forces for Max Battles, making it easier to catch gargantuan Pokémon and earn Max Particles to boost their skills for future challenges. These updates enhance gameplay, helping users find shiny Gigantamax Pokémon they might not see locally,” said Tenorshare’s CEO when discussing the new features.

How to Install the iAnyGo iOS App

For new users, the iAnyGo installation process is simple. Here’s a quick overview of the steps:

Go to the official website to download and install the iAnyGo iOS Assistant on your computer.Sign in using Apple ID and click “Install iAnyGo iOS App” button. You can extend its validity every seven days by signing in with your Apple ID on iAnyGo App—no computer is needed after the initial setup.

How to Get Dynamax and Gigantamax Pokémon on new Max Battles

The iAnyGo iOS App enhances your Pokémon experience by allowing you to explore any location virtually. Follow these steps to find and battle Dynamax and Gigantamax Pokémon in the new Max Battles in Pokémon GO.

Open the iAnyGo iOS App and tap the fifth button “D-Max” on the right to view Dynamax and Gigantamax Pokémon. You can view these gargantuan Pokémon by zooming in or out on the screen.Tap the “Go” button, and you can go over to catch Dynamax and Gigantamax Pokémon. You can also click the “copy” button to copy longitude and latitude coordinates and share them with your friends.

Additionally, with its features like Change Location, PokeStop Mode, and Single-Spot Movement, users can spoof Pokémon GO on iPhone without physically moving. iAnyGo iOS App is a reliable Pokémon GO Spoofer for iOS 18.

Pricing for iAnyGo iOS App

The iAnyGo iOS App is available in multiple packages designed to fit users’ needs:
1 Month/1 Device: $14.99
1 Quarter/1 Device: $39.99
1 Year/1 Device: $79.99
Lifetime/1 Device: $99.99

For more details on purchasing, please visit iAnyGo iOS App Pricing.

About Tenorshare

Tenorshare specializes in iOS, Android, Windows, and Mac platforms, focusing on core technology research. It is a leading software provider with millions of users that use its tools related to data transfer, data recovery, system repair, unlocking phones, and many more.

More information: https://www.tenorshare.com/

Facebook: https://www.facebook.com/TenorshareOfficial/

Twitter: https://twitter.com/Tenorshare_Inc

YouTube: https://www.youtube.com/user/TenorshareOfficial/videos

TikTok: https://www.tiktok.com/@tenorshare_tech_tips

This release was issued through Send2Press® on behalf of the news source. For more information, visit Send2Press Newswire at https://www.send2press.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dynamax-pokemon-best-pokemon-go-spoofer-2024-for-ios-without-computer-302297721.html

SOURCE Tenorshare Co. Ltd.

Continue Reading

Trending